Jung H, Kim JS, Lee KH, Tizaoui K, Terrazzino S, Cargnin S, Smith L, Koyanagi A, Jacob L, Li H, et al. Roles of microRNAs in inflammatory bowel disease. Int J Biol Sci. 2021;17(8):2112–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Altaf-Ul-Amin M, Karim MB, Hu P, Ono N, Kanaya S. Discovery of inflammatory bowel disease-associated miRNAs using a novel bipartite clustering approach. BMC Med Genomics. 2020;13(Suppl 3):10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kondo A, Ma S, Lee M, Ortiz V, Traum D, Schug J, Wilkins B, Terry N, Lee H, Kaestner K. Highly multiplexed image analysis of intestinal tissue sections in patients with inflammatory bowel disease. Gastroenterology. 2021;161(6):1940.
Article
CAS
PubMed
Google Scholar
Wen S, He L, Zhong Z, Zhao R, Weng S, Mi H, Liu F. Stigmasterol restores the balance of Treg/Th17 cells by activating the butyrate-PPARgamma axis in colitis. Front Immunol. 2021;12: 741934.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lechner K, Mott S, Al-Saifi R, Knipfer L, Wirtz S, Atreya R, Vieth M, Rath T, Fraass T, Winter Z, et al. Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis. Gastroenterology. 2021;161(4):1270.
Article
CAS
PubMed
Google Scholar
Friedrich M, Pohin M, Powrie F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity. 2019;50(4):992–1006.
Article
CAS
PubMed
Google Scholar
Yang X, He Q, Guo Z, Xiong F, Li Y, Pan Y, Gao C, Li L, He C. MicroRNA-425 facilitates pathogenic Th17 cell differentiation by targeting forkhead box O1 (Foxo1) and is associated with inflammatory bowel disease. Biochem Biophys Res Commun. 2018;496(2):352–8.
Article
CAS
PubMed
Google Scholar
Singh UP, Murphy AE, Enos RT, Shamran HA, Singh NP, Guan H, Hegde VL, Fan D, Price RL, Taub DD, et al. miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses. Immunology. 2014;143(3):478–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sanctuary MR, Huang RH, Jones AA, Luck ME, Aherne CM, Jedlicka P, de Zoeten EF, Collins CB. miR-106a deficiency attenuates inflammation in murine IBD models. Mucosal Immunol. 2019;12(1):200–11.
Article
CAS
PubMed
Google Scholar
Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and its modified formulations on inflammatory bowel disease (IBD): the story so far and future outlook. Pharmaceutics. 2021;13(4):484.
Article
CAS
PubMed
PubMed Central
Google Scholar
Takuse Y, Watanabe M, Inoue N, Ozaki R, Ohtsu H, Saeki M, Katsumata Y, Hidaka Y, Iwatani Y. Association of IL-10-regulating MicroRNAs in peripheral blood mononuclear cells with the pathogenesis of autoimmune thyroid disease. Immunol Invest. 2017;46(6):590–602.
Article
CAS
PubMed
Google Scholar
Schmetterer KG, Pickl WF. The IL-10/STAT3 axis: Contributions to immune tolerance by thymus and peripherally derived regulatory T-cells. Eur J Immunol. 2017;47(8):1256–65.
Article
CAS
PubMed
Google Scholar
Kalla R, Adams AT, Ventham NT, Kennedy NA, White R, Clarke C, Ivens A, Bergemalm D, Vatn S, Lopez-Jimena B, et al. Whole blood profiling of T-cell derived miRNA allows the development of prognostic models in inflammatory bowel disease. J Crohns Colitis. 2020;14(12):1724.
Article
CAS
PubMed
Google Scholar
Zhao J, He Z, Wang J. MicroRNA-124: a key player in microglia-mediated inflammation in neurological diseases. Front Cell Neurosci. 2021;15: 771898.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shi Y, Dai S, Qiu C, Wang T, Zhou Y, Xue C, Yao J, Xu Y. MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease. Mucosal Immunol. 2020;13(2):303–12.
Article
CAS
PubMed
Google Scholar
Lai C, Yeh K, Liu B, Chang T, Chang C, Liao Y, Liu Y, Her G. MicroRNA-21 plays multiple oncometabolic roles in colitis-associated carcinoma and colorectal cancer via the PI3K/AKT, STAT3, and PDCD4/TNF-α signaling pathways in zebrafish. Cancers. 2021;13(21):5565.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rodriguez-Galan A, Fernandez-Messina L, Sanchez-Madrid F. Control of immunoregulatory molecules by miRNAs in T cell activation. Front Immunol. 2018;9:2148.
Article
PubMed
PubMed Central
Google Scholar
Garavelli S, De Rosa V, de Candia P. The multifaceted interface between cytokines and microRNAs: an ancient mechanism to regulate the good and the bad of inflammation. Front Immunol. 2018;9:3012.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scalavino V, Liso M, Cavalcanti E, Gigante I, Lippolis A, Mastronardi M, Chieppa M, Serino G. miR-369-3p modulates inducible nitric oxide synthase and is involved in regulation of chronic inflammatory response. Sci Rep. 2020;10(1):15942.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kastle M, Bartel S, Geillinger-Kastle K, Irmler M, Beckers J, Ryffel B, Eickelberg O, Krauss-Etschmann S. microRNA cluster 106a–363 is involved in T helper 17 cell differentiation. Immunology. 2017;152(3):402–13.
Article
PubMed
PubMed Central
Google Scholar
Wu Q, Xie S, Zhu Y, Chen J, Tian J, Xiong S, Wu C, Ye Y, Peng Y. Wogonin strengthens the therapeutic effects of mesenchymal stem cells in DSS-induced colitis via promoting IL-10 production. Oxid Med Cell Longev. 2021;2021:5527935.
Article
PubMed
PubMed Central
Google Scholar
Pei XF, Cao LL, Huang F, Qiao X, Yu J, Ye H, Xi CL, Zhou QC, Zhang GF, Gong ZL. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease. Pathol Res Pract. 2018;214(8):1095–104.
Article
CAS
PubMed
Google Scholar
Farideh Talebi SG. Wing Fuk Chan, Farshid Noorbakhsh: MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. Journal of Neuroinflammatio. 2017;14:55.
Article
Google Scholar
Harbour SN, Maynard CL, Zindl CL, Schoeb TR, Weaver CT. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc Natl Acad Sci U S A. 2015;112(22):7061–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Osorio-Barrios F, Navarro G, Campos J, Ugalde V, Prado C, Raich I, Contreras F, Lopez E, Espinoza A, Lladser A, et al. The heteromeric complex formed by dopamine receptor D5 and CCR9 leads the gut homing of CD4(+) T cells upon inflammation. Cell Mol Gastroenterol Hepatol. 2021;12(2):489–506.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nie J, Zhao Q. Lnc-ITSN1-2, derived from RNA sequencing, correlates with increased disease risk, activity and promotes CD4 T cell activation, proliferation and Th1/Th17 cell differentiation by serving as a ceRNA for IL-23R via sponging miR-125a in inflammatory bowel disease. Front Immunol. 2020;11:852.
Article
CAS
PubMed
PubMed Central
Google Scholar
Inácio DP, Amado T, Silva-Santos B, Gomes AQ. Control of T cell effector functions by miRNAs. Cancer Lett. 2018;427:63–73.
Article
PubMed
Google Scholar
Omidbakhsh A, Saeedi M, Khoshnia M, Marjani A, Hakimi S. Micro-RNAs -106a and -362-3p in peripheral blood of inflammatory bowel disease patients. Open Biochem J. 2018;12:78–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou R, Chang Y, Liu J, Chen M, Wang H, Huang M, Liu S, Wang X, Zhao Q. JNK pathway-associated phosphatase/DUSP22 suppresses CD4(+) T-cell activation and Th1/Th17-cell differentiation and negatively correlates with clinical activity in inflammatory bowel disease. Front Immunol. 2017;8:781.
Article
PubMed
PubMed Central
Google Scholar
Veenbergen S, Li P, Raatgeep HC, Lindenbergh-Kortleve DJ, Simons-Oosterhuis Y, Farrel A, Costes LMM, Joosse ME, van Berkel LA, de Ruiter LF, et al. IL-10 signaling in dendritic cells controls IL-1beta-mediated IFNgamma secretion by human CD4(+) T cells: relevance to inflammatory bowel disease. Mucosal Immunol. 2019;12(5):1201–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tachibana M, Watanabe N, Koda Y, Oya Y, Kaminuma O, Katayama K, Fan Z, Sakurai F, Kawabata K, Hiroi T, et al. Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production. Int Immunol. 2020;32(3):187–201.
Article
CAS
PubMed
Google Scholar
Bo Liu D, S L Tonkonogy, and R Balfour Sartor: IL-10 produced by antigen presenting cells inhibits bacterialresponsive TH1/TH17 cells and suppresses colitis in mice. Gastroenterology 2011;141(2): 653.
Mas-Orea X, Sebert M, Benamar M, Petitfils C, Blanpied C, Saoudi A, Deraison C, Barreau F, Cenac N, Dietrich G. Peripheral opioid receptor blockade enhances epithelial damage in piroxicam-accelerated colitis in IL-10-deficient mice. Int J Mol Sci. 2021;22(14):7387.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zheng W, Song H, Luo Z, Wu H, Chen L, Wang Y, Cui H, Zhang Y, Wang B, Li W, et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway. Proc Natl Acad Sci U S A. 2021;118(11):2017.
Article
Google Scholar
Ruiz N, Kamel A, Liu X, Pham A, Forsmark C, Glover S. Failure to thrive: a severe manifestation of interleukin 10 receptor A mutation adult inflammatory bowel disease. JPEN J Parenteral Enteral Nut. 2021;46(1):238.
Article
Google Scholar
Su W, Yu Y, Xu X, Wang XQ, Huang JB, Xu CD, Xiao Y. Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases. World J Gastroenterol. 2021;27(1):92–106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Okada Y, Tsuzuki Y, Sugihara N, Nishii S, Shibuya N, Mizoguchi A, Itoh S, Tanemoto R, Inaba K, Hanawa Y, et al. Novel probiotic yeast from miso promotes regulatory dendritic cell IL-10 production and attenuates DSS-induced colitis in mice. J Gastroenterol. 2021;56(9):829.
Article
CAS
PubMed
Google Scholar
Abernathy-Close L, Barron MR, George JM, Dieterle MG, Vendrov KC, Bergin IL, Young VB: Intestinal inflammation and altered gut microbiota associated with inflammatory bowel disease render mice susceptible to clostridioides difficile colonization and infection. mBio 2021; 12(3): 273320.
Liu S, Zhang S, Lv X, Lu J, Ren C, Zeng Z, Zheng L, Zhou X, Fu H, Zhou D, et al. Limonin ameliorates ulcerative colitis by regulating STAT3/miR-214 signaling pathway. Int Immunopharmacol. 2019;75: 105768.
Article
CAS
PubMed
Google Scholar
Hedl M, Sun R, Huang C, Abraham C. STAT3 and STAT5 signaling thresholds determine distinct regulation for innate receptor-induced inflammatory cytokines, and STAT3/STAT5 disease variants modulate these outcomes. J Immunol. 2019;203(12):3325–38.
Article
PubMed
Google Scholar